Support for The Effectiveness of Discontinuing Bisphosphonates ("EDGE") Study
Maxine K. signed
just now
Adam B. signed
just now
The EDGE Study is seeking clinics and practices to participate in a pragmatic clinical trial to determine the long-term effectiveness and safety of oral bisphosphonates on osteoporosis. This is a question of key importance to our patients and the medical community.
Click here to take our three minute site assessment questionnaire.
The EDGE (Effectiveness of DiscontinuinG biphosphonatEs) Study planning grant is sponsored by the NIH and is being coordinated by the University of Alabama at Birmingham.
Selected practices will receive:
iPads to facilitate participant recruitment, informed consent and randomization Receive up to $18,125 in compensation for the first 20 participants enrolled 1 CME creditTo participate in the EDGE study, practices will:
Identify and enroll at least 20 women, aged 65 or older who have taken alendronate for at least three years Participate in a short introductory webinar and web-based training session Have access to Wi-Fi Internet Complete brief (5 minute) annual follow-up fracture assessment with participantsInitial study visit lasting 30 minutes, NO labs, and NO monitoring visits for the EDGE study.
Participants will be randomized to continue or discontinue their alendronate.
Participant enrollment is expedited with improved comprehension using an informed consent delivered on an iPad. Participants complete surveys from the central coordinating center after enrollment. Participants will be compensated up to $225 for enrollment and all completed surveys.
Please express your interest in being a future study site by completing this brief site assessment questionnaire.
Contact the EDGE study team at 1-855-406-7232 with questions, or visit the theedgestudy.com for more information.
Share on Facebook
Comment
See More 0